Background
Depressive symptoms are common in older adults and associated with increased morbidity and cognitive decline. These symptoms occur during preclinical and prodromal stages of Alzheimer’s disease (AD), but their relationship to tau, one of the main AD proteinopathies, is poorly understood.
Objective
The objective of this study was to investigate the cross-sectional association between depressive symptoms and cerebral tau (18F T807 (a.k.a. 18F-AV-1451) tau positron emission tomography (PET) imaging) in cognitively normal (CN) older adults.
Methods
We measured depressive symptoms using the Geriatric Depression Scale (GDS), and in vivo cerebral tau using T807 PET in 111 CN older adults. We employed general linear regression models to evaluate the relationship of GDS score regressed on entorhinal cortex (EC) or inferior temporal (IT) tau in separate backward elimination models. Other predictors included age, sex, and in secondary analyses, amyloid (Pittsburgh Compound B (PiB) PET).
Results
Higher GDS was significantly associated with greater IT tau (partial r=0.188, p=0.050) and marginally associated with greater EC tau (partial r=0.183, p=0.055). In additional analyses including both linear and quadratic age terms, we found a significant u-shaped relation of GDS to age (p=0.001).
Conclusions
Results suggest that IT and EC tau are modestly associated with depressive symptoms in CN older adults. Findings suggest a link between depressive symptoms and tau mediated neurodegeneration in a region vulnerable in AD. Future longitudinal studies examining the association of more severe depressive symptoms and cerebral tau accumulation are needed to substantiate this finding and to guide prevention and treatment in AD.